Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,16000586,IC50,"The antitumor potency of the agents in vitro was in the order olomoucine (IC50, 56 micromol/L) < bohemine (IC50, 27 micromol/L) < CYC202 (IC50, 15 micromol/L), corresponding to their activities as cyclin-dependent kinase inhibitors.","In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202. ",IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16000586/),[μM] / [l],56,218253,DB02116,Olomoucine
,16000586,IC50,"The antitumor potency of the agents in vitro was in the order olomoucine (IC50, 56 micromol/L) < bohemine (IC50, 27 micromol/L) < CYC202 (IC50, 15 micromol/L), corresponding to their activities as cyclin-dependent kinase inhibitors.","In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202. ",IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16000586/),[μM] / [l],27,218254,DB02116,Olomoucine
,16000586,IC50,"The antitumor potency of the agents in vitro was in the order olomoucine (IC50, 56 micromol/L) < bohemine (IC50, 27 micromol/L) < CYC202 (IC50, 15 micromol/L), corresponding to their activities as cyclin-dependent kinase inhibitors.","In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202. ",IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16000586/),[μM] / [l],15,218255,DB02116,Olomoucine
,16000586,oral bioavailability,"CYC202 displayed the slowest clearance from plasma and the highest tumor uptake, with oral bioavailability of 86%.","In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202. ",F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16000586/),%,86,218256,DB02116,Olomoucine
